Channels

Sun, Oct 20 7:19am

0 Medical Equipment And Devices Industry


Medical Equipment And Devices Industry


Medical Equipment And Devices
1 of 133
ABT $82.79 0.41 (0.50%)
Abbott Laboratories AbbottNews
NYSE: ABT $149 Billion Large-Cap. Show More

ABT Profile

Market Cap 149 Billion
ABT Description

Abbott manufactures and markets medical devices, blood glucose monitoring kits, nutritional healthcare products, diagnostic products and equipment, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, and molecular and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.


Visit Website

ABT Earnings

EPS 0.57 P/E Ratio 59.16
Previous Wed, Jul 17, 2019
Latest Wed, Oct 16, 2019 (4 days ago) Price +0.99%

ABT Dividend

Yield 1.55% / $1.28
Ex-Date Fri, Oct 11, 2019 (9 days ago)
Pay Date Fri, Nov 15, 2019
History 136 Payments (Quarterly)

ABT Charts

All Time High $88.76 on Tue, Jul 23, 2019.
$65.44
1 Year
$88.76
Dec 24, 2018
Jul 23, 2019


Medical Equipment And Devices
2 of 133
MDT $108.12 0.39 (0.36%)
Medtronic Medtronic
NYSE: MDT $146 Billion Large-Cap. Show More

MDT Profile

Market Cap 146 Billion
MDT Description

Medtronic PLC is one of the largest medical device companies, develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for about 45% of the company's total sales.


Visit Website

MDT Earnings

EPS 0.64 P/E Ratio 24.06
Previous Tue, Aug 20, 2019
Latest Tue, Nov 19, 2019 (In 30 days)

MDT Dividend

Yield 2.00% / $2.16
Ex-Date Thu, Sep 26, 2019 (24 days ago)
Pay Date Fri, Oct 18, 2019
History 138 Payments (Quarterly)

MDT Charts

All Time High $112.05 on Tue, Sep 24, 2019.
$81.66
1 Year
$112.05
Jan 8, 2019
Sep 24, 2019


Medical Equipment And Devices
3 of 133
TMO $281.42 0.17 (0.06%)
Thermo Fisher Scientific thermofisher
NYSE: TMO $118 Billion Large-Cap. Show More

TMO Profile

Market Cap 118 Billion
TMO Description

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments: analytical technologies (23% of sales); specialty diagnostic products (15%); life science solutions (26%); and lab products and services (41%).


Visit Website

TMO Earnings

EPS 2.80 P/E Ratio 35.21
Previous Wed, Jul 24, 2019
Latest Wed, Oct 23, 2019 (In 3 days)

TMO Dividend

Yield 0.27% / $0.76
Ex-Date Mon, Sep 16, 2019 (34 days ago)
Pay Date Tue, Oct 15, 2019
History 32 Payments (Quarterly)

TMO Charts

All Time High $305.45 on Wed, Jul 3, 2019.
$208.34
1 Year
$305.45
Dec 26, 2018
Jul 3, 2019


Medical Equipment And Devices
4 of 133
DHR $138.01 0.24 (0.17%)
Danaher
NYSE: DHR $100 Billion Large-Cap. Show More

DHR Profile

Market Cap 100 Billion
DHR Description

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in four segments: life sciences (33% of 2018 sales), diagnostics (31%), environmental and applied solutions (22%), and dental (14%). In 2019, Danaher plans to separate its dental business from the organization through an initial public offering, and Danaher also plans to acquire GE's Biopharma business, which will add to its life sciences segment.


Visit Website

DHR Earnings

EPS 0.99 P/E Ratio 26.35
Previous Thu, Jul 18, 2019
Latest Thu, Oct 24, 2019 (In 4 days)

DHR Dividend

Yield 0.49% / $0.68
Ex-Date Thu, Sep 26, 2019 (24 days ago)
Pay Date Fri, Oct 25, 2019
History 107 Payments (Quarterly)

DHR Charts

All Time High $147.33 on Fri, Sep 20, 2019.
$94.59
1 Year
$147.33
Dec 24, 2018
Sep 20, 2019


Medical Equipment And Devices
5 of 133
SYK $215.32 0.24 (0.11%)
Stryker
NYSE: SYK $82 Billion Large-Cap. Show More

SYK Profile

Market Cap 82 Billion
SYK Description

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Approximately 35% of Stryker's total revenue currently comes from outside the United States.


Visit Website

SYK Earnings

EPS 1.29 P/E Ratio 53.35
Previous Thu, Jul 25, 2019
Latest Tue, Oct 29, 2019 (In 9 days)

SYK Dividend

Yield 0.97% / $2.08
Ex-Date Fri, Sep 27, 2019 (23 days ago)
Pay Date Thu, Oct 31, 2019
History 59 Payments (Quarterly)

SYK Charts

All Time High $223.45 on Fri, Aug 30, 2019.
$144.75
1 Year
$223.45
Dec 26, 2018
Aug 30, 2019


Medical Equipment And Devices
6 of 133
BDX $258.59 1.79 (0.70%)
Becton Dickinson
NYSE: BDX $70 Billion Large-Cap. Show More

BDX Profile

Market Cap 70 Billion
BDX Description

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. International revenue accounts for 45% of the company's business. With CareFusion, BD has entered into medical systems (such as infusion pumps and ventilators) as well as procedural solutions businesses. The Bard deal gives the company a presence in urology, vascular, and oncology.


Visit Website

BDX Earnings

EPS 1.53 P/E Ratio 72.20
Previous Tue, Aug 6, 2019
Latest Tue, Nov 5, 2019 (In 16 days)

BDX Dividend

Yield 1.19% / $3.08
Ex-Date Fri, Sep 6, 2019 (44 days ago)
Pay Date Mon, Sep 30, 2019
History 136 Payments (Quarterly)

BDX Charts

All Time High $265.87 on Mon, Oct 1, 2018.
$208.62
1 Year
$264.74
Dec 26, 2018
Sep 6, 2019


Medical Equipment And Devices
7 of 133
ISRG $566.25 36.85 (6.96%)
Intuitive Surgical
NASDAQ: ISRG $60 Billion Large-Cap. Show More

ISRG Profile

Market Cap 60 Billion
ISRG Description

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 5,000 da Vinci systems in hospitals worldwide, with 3,200 installations in the United States and a growing number in emerging markets.


Visit Website

ISRG Earnings

EPS 2.76 P/E Ratio 51.10
Previous Thu, Jul 18, 2019
Latest Thu, Oct 17, 2019 (3 days ago) Price +6.79%

ISRG Dividend

Yield --
Ex-Date --
Pay Date --
History --

ISRG Charts

All Time High $589.32 on Fri, Apr 12, 2019.
$430.24
1 Year
$589.32
Dec 24, 2018
Apr 12, 2019


Medical Equipment And Devices
8 of 133
BSX $38.47 0.30 (0.79%)
Boston Scientific
NYSE: BSX $59 Billion Large-Cap. Show More

BSX Profile

Market Cap 59 Billion
BSX Description

Boston Scientific Corp produces less-invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract tests, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.


Visit Website

BSX Earnings

EPS 0.11 P/E Ratio 32.07
Previous Wed, Jul 24, 2019
Latest Wed, Oct 23, 2019 (In 3 days)

BSX Dividend

Yield --
Ex-Date --
Pay Date --
History --

BSX Charts

$31.56
1 Year
$43.84
Dec 24, 2018
Sep 6, 2019


Medical Equipment And Devices
9 of 133
EW $227.46 0.34 (0.15%)
Edwards Lifesciences
NYSE: EW $45 Billion Large-Cap. Show More

EW Profile

Market Cap 45 Billion
EW Description

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of heart disease. Its key products include surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters and retractors, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.


Visit Website

EW Earnings

EPS 1.16 P/E Ratio 49.23
Previous Tue, Jul 23, 2019
Latest Wed, Oct 23, 2019 (In 3 days)

EW Dividend

Yield --
Ex-Date --
Pay Date --
History --

EW Charts

All Time High $230.19 on Fri, Oct 11, 2019.
$136.44
1 Year
$230.19
Oct 29, 2018
Oct 11, 2019


Medical Equipment And Devices
10 of 133
BAX $87.99 0.14 (0.16%)
Baxter International
NYSE: BAX $45 Billion Large-Cap. Show More

BAX Profile

Market Cap 45 Billion
BAX Description

Baxter manufactures medical products across seven major reported business segments. The renal segment (33% of 2018 sales) includes peritoneal dialysis and hemodialysis products for chronically ill patients while its acute therapies segment (5%) offers kidney or other organ support tools in intensive care situations. The medication delivery segment (24% of sales) sells IV pumps, administrative sets, and solutions while its nutrition segment (8% of sales) offers parenteral nutrition therapies. The pharmaceuticals segments (19% of sales) offers injectable drugs, anesthetic gases, and compounding services. The advanced surgery segment (7% of sales) provides hemostastic products and biosurgical sealants. Contract manufacturing rounds out the remaining 5% of sales.


Visit Website

BAX Earnings

EPS 0.67 P/E Ratio 26.63
Previous Thu, Jul 25, 2019
Latest Thu, Oct 24, 2019 (In 4 days)

BAX Dividend

Yield 1.00% / $0.88
Ex-Date Thu, Aug 29, 2019 (52 days ago)
Pay Date Tue, Oct 1, 2019
History 115 Payments (Quarterly)

BAX Charts

All Time High $89.93 on Fri, Sep 6, 2019.
$61.05
1 Year
$89.93
Oct 31, 2018
Sep 6, 2019


Medical Equipment And Devices
11 of 133
ILMN $309.44 1.11 (0.36%)
Illumina
NASDAQ: ILMN $43 Billion Large-Cap. Show More

ILMN Profile

Market Cap 43 Billion
ILMN Description

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates revenue from sequencing tools and dedicated consumables (about 70% of sales). Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (12% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Services account for 18% of sales and include basic maintenance services, clinical lab applications (such as noninvasive prenatal, oncology, and rare-disease screening), and whole genome sequencing.


Visit Website

ILMN Earnings

EPS 2.01 P/E Ratio 57.38
Previous Mon, Jul 29, 2019
Latest Thu, Oct 24, 2019 (In 4 days)

ILMN Dividend

Yield --
Ex-Date --
Pay Date --
History --

ILMN Charts

$263.30
1 Year
$380.76
Sep 10, 2019
Jul 10, 2019


Medical Equipment And Devices
12 of 133
ZBH $137.61 0.90 (0.65%)
Zimmer Biomet Holdings
NYSE: ZBH $29 Billion Large-Cap. Show More

ZBH Profile

Market Cap 29 Billion
ZBH Description

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 60% of total revenue is derived from sales of large joints, another 22% comes from extremities and trauma; the remaining portion is primarily related to spine and dental products.


Visit Website

ZBH Earnings

EPS 0.65 P/E Ratio 0.00
Previous Fri, Jul 26, 2019
Latest Tue, Nov 5, 2019 (In 16 days)

ZBH Dividend

Yield 0.70% / $0.96
Ex-Date Fri, Sep 27, 2019 (23 days ago)
Pay Date Thu, Oct 31, 2019
History 31 Payments (Quarterly)

ZBH Charts

All Time High $143.57 on Fri, Sep 13, 2019.
$96.99
1 Year
$143.57
Dec 24, 2018
Sep 13, 2019


Medical Equipment And Devices
13 of 133
A $74.57 0.35 (0.47%)
Agilent Technologies
NYSE: A $24 Billion Large-Cap. Show More

A Profile

Market Cap 24 Billion
A Description

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (46% of fiscal 2018 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (19%). Just over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse with operations in the U.S. (29%) and China (21%) representing the largest country concentrations.


Visit Website

A Earnings

EPS 0.61 P/E Ratio 21.41
Previous Tue, May 14, 2019
Latest Wed, Aug 14, 2019 (67 days ago) Price +0.00%

A Dividend

Yield 0.88% / $0.66
Ex-Date Mon, Sep 30, 2019 (20 days ago)
Pay Date Wed, Oct 23, 2019
History 31 Payments (Quarterly)

A Charts

$61.01
1 Year
$82.27
Oct 24, 2018
Mar 21, 2019


Medical Equipment And Devices
14 of 133
IDXX $282.83 0.70 (0.25%)
IDEXX Laboratories
NASDAQ: IDXX $23 Billion Large-Cap. Show More

IDXX Profile

Market Cap 23 Billion
IDXX Description

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. Idexx gets about 39% of its revenue from outside the United States.


Visit Website

IDXX Earnings

EPS 1.46 P/E Ratio 51.29
Previous Thu, Aug 1, 2019
Latest Thu, Oct 31, 2019 (In 11 days)

IDXX Dividend

Yield --
Ex-Date --
Pay Date --
History --

IDXX Charts

All Time High $292.17 on Fri, Jul 19, 2019.
$176.11
1 Year
$292.17
Jan 3, 2019
Jul 19, 2019


Medical Equipment And Devices
15 of 133
SNN $47.78 0.07 (0.15%)
Smith & Nephew SNATS
NYSE: SNN $20 Billion Large-Cap. Show More

SNN Profile

Market Cap 20 Billion
SNN Description

Smith & Nephew designs, manufactures, and markets orthopedic devices and wound-care solutions. Approximately three fourths of the U.K.-based firm's revenue comes from knee replacements, hip implants, nails, fixation devices, and arthroscopy tools. The remaining 25% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from developed European and Asian markets, 40% is from the United States, and emerging markets account for the remainder.


Visit Website

SNN Earnings

EPS 0.00 P/E Ratio 25.44
Previous Thu, Feb 7, 2019
Latest Wed, Jul 31, 2019 (81 days ago) Price +24.62%

SNN Dividend

Yield 1.84% / $0.88
Ex-Date Thu, Apr 4, 2019 (199 days ago)
Pay Date Wed, May 8, 2019
History 40 Payments (Biannual)

SNN Charts

All Time High $48.93 on Thu, Sep 26, 2019.
$32.22
1 Year
$48.93
Oct 29, 2018
Sep 26, 2019


Medical Equipment And Devices
16 of 133
RMD $131.21 0.42 (0.32%)
ResMed
NYSE: RMD $19 Billion Large-Cap. Show More

RMD Profile

Market Cap 19 Billion
RMD Description

ResMed Inc is one of the largest global respiratory medical devices companies, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns 65% of revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payor in the out-of-hospital setting.


Visit Website

RMD Earnings

EPS 0.48 P/E Ratio 31.80
Previous Thu, Jul 25, 2019
Latest Thu, Oct 24, 2019 (In 4 days)

RMD Dividend

Yield 1.19% / $1.56
Ex-Date Wed, Aug 14, 2019 (67 days ago)
Pay Date Thu, Sep 19, 2019
History 29 Payments (Quarterly)

RMD Charts

All Time High $141.25 on Fri, Sep 6, 2019.
$90.64
1 Year
$141.25
Jan 29, 2019
Sep 6, 2019


Medical Equipment And Devices
17 of 133
MTD $680.50 9.68 (1.44%)
Mettler-Toledo
NYSE: MTD $18 Billion Large-Cap. Show More

MTD Profile

Market Cap 18 Billion
MTD Description

Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (50% of sales), industrial (42%), and food retail industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances.


Visit Website

MTD Earnings

EPS 5.15 P/E Ratio 38.09
Previous Thu, Aug 1, 2019
Latest Thu, Nov 7, 2019 (In 18 days)

MTD Dividend

Yield --
Ex-Date --
Pay Date --
History --

MTD Charts

$500.74
1 Year
$873.51
Jan 3, 2019
Jul 3, 2019


Medical Equipment And Devices
18 of 133
TFX $328.31 0.27 (0.08%)
Teleflex
NYSE: TFX $16 Billion Large-Cap. Show More

TFX Profile

Market Cap 16 Billion
TFX Description

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the vascular access and surgical areas. The firm reports in eight primary segments: vascular North America (13% of 2018 sales), interventional North America (11%), anesthesia North America (8%), surgical North America (7%), Europe, Middle East, Africa (25%), Asia (12%), original-equipment manufacturing (8%), and all other (16%). Geographic exposure for the business is primarily in the U.S., which accounts for 60% of revenue, with international markets making up the remainder.


Visit Website

TFX Earnings

EPS 1.81 P/E Ratio 179.22
Previous Thu, May 2, 2019
Latest Thu, Aug 1, 2019 (80 days ago) Price +0.00%

TFX Dividend

Yield 0.41% / $1.36
Ex-Date Wed, Aug 14, 2019 (67 days ago)
Pay Date Mon, Sep 16, 2019
History 139 Payments (Quarterly)

TFX Charts

$226.02
1 Year
$373.90
Dec 24, 2018
Aug 20, 2019


Medical Equipment And Devices
19 of 133
WAT $215.75 0.99 (0.46%)
Waters
NYSE: WAT $15 Billion Large-Cap. Show More

WAT Profile

Market Cap 15 Billion
WAT Description

Water offers liquid chromatography, mass spectrometry, and thermal analysis tools primarily to biopharmaceutical and other industrial customers. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. For Waters, instruments/informatics, services, and consumables account for approximately 50%, 34%, and 17% of sales, respectively.


Visit Website

WAT Earnings

EPS 2.09 P/E Ratio 31.32
Previous Tue, Jul 30, 2019
Latest Tue, Oct 29, 2019 (In 9 days)

WAT Dividend

Yield --
Ex-Date --
Pay Date --
History --

WAT Charts

$167.94
1 Year
$255.21
Oct 23, 2018
Apr 1, 2019


Medical Equipment And Devices
20 of 133
COO $287.81 4.44 (1.52%)
Cooper Companies
NYSE: COO $15 Billion Large-Cap. Show More

COO Profile

Market Cap 15 Billion
COO Description

Cooper Companies operates two units: CooperVision and CooperSurgical. Accounting for approximately 75% of total sales, CooperVision is the the second largest player in the oligopolistic contact lens market. Over 50% of CooperVision's sales are in international territories. The second unit, CooperSurgical, develops and manufactures diagnostic and surgical products for gynecologists and obstetricians, including the Paragard IUD, which Cooper acquired from Teva in 2017.


Visit Website

COO Earnings

EPS 2.42 P/E Ratio 102.76
Previous Thu, May 30, 2019
Latest Thu, Aug 29, 2019 (52 days ago) Price +0.00%

COO Dividend

Yield 0.02% / $0.06
Ex-Date Mon, Jul 22, 2019 (90 days ago)
Pay Date Wed, Aug 7, 2019
History 55 Payments (Quarterly)

COO Charts

$228.65
1 Year
$344.32
Dec 24, 2018
Aug 13, 2019


Medical Equipment And Devices
21 of 133
ALGN $213.88 0.04 (0.02%)
Align Technology
NASDAQ: ALGN $14 Billion Large-Cap. Show More

ALGN Profile

Market Cap 14 Billion
ALGN Description

Align Technology provides a clear aligner therapy system, intra-oral scanners, and computer-aided design/computer-aided manufacture digital services used in dentistry and orthodontics.


Visit Website

ALGN Earnings

EPS 1.84 P/E Ratio 57.21
Previous Wed, Jul 24, 2019
Latest Wed, Oct 23, 2019 (In 3 days)

ALGN Dividend

Yield --
Ex-Date --
Pay Date --
History --

ALGN Charts

$169.84
1 Year
$334.64
Sep 9, 2019
May 16, 2019


Medical Equipment And Devices
22 of 133
HOLX $49.93 0.58 (1.18%)
Hologic
NASDAQ: HOLX $13 Billion Large-Cap. Show More

HOLX Profile

Market Cap 13 Billion
HOLX Description

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: breast health (38% of sales), diagnostics (26%) surgical (13%), medical aesthetics (10%), and skeletal health (3%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics, and the purchase of Cynosure establishes a footprint in the cosmetic laser market. The United States accounts for the largest portion of the firm's revenue (74%), followed by Europe (12%), Asia (9%), and other international markets (5%). Hologic is headquartered in Bedford, Massachusetts.


Visit Website

HOLX Earnings

EPS 0.35 P/E Ratio 0.00
Previous Wed, Jul 31, 2019
Latest Wed, Nov 6, 2019 (In 17 days)

HOLX Dividend

Yield --
Ex-Date --
Pay Date --
History --

HOLX Charts

All Time High $52.19 on Wed, Jul 31, 2019.
$37.47
1 Year
$52.19
Oct 29, 2018
Jul 31, 2019


Medical Equipment And Devices
23 of 133
STE $143.37 0.22 (0.15%)
STERIS PLC
NYSE: STE $13 Billion Large-Cap. Show More

STE Profile

Market Cap 13 Billion
STE Description

Steris is a U.K.-based medical device company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its 2015 inversion, the firm continues to derive roughly 70% of revenue from its U.S. operations, 10% from the United Kingdom, and the remaining 20% from other international regions.


Visit Website

STE Earnings

EPS 1.28 P/E Ratio 30.77
Previous Mon, May 13, 2019
Latest Mon, Aug 5, 2019 (76 days ago) Price +0.00%

STE Dividend

Yield 1.03% / $1.48
Ex-Date Mon, Sep 9, 2019 (41 days ago)
Pay Date Thu, Sep 26, 2019
History 59 Payments (Quarterly)

STE Charts

All Time High $156.66 on Fri, Aug 30, 2019.
$99.14
1 Year
$156.66
Dec 26, 2018
Aug 30, 2019


Medical Equipment And Devices
24 of 133
XRAY $54.90 0.05 (0.09%)
Dentsply
NASDAQ: XRAY $11 Billion Large-Cap. Show More

XRAY Profile

Market Cap 11 Billion
XRAY Description

Dentsply Sirona is one of the world's largest manufacturers and distributors of dental supplies and equipment. Its products include dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. Over half of its products are sold through dental distributors, and approximately 68% of Dentsply's sales are outside the U.S.


Visit Website

XRAY Earnings

EPS 0.16 P/E Ratio 0.00
Previous Fri, May 3, 2019
Latest Fri, Aug 2, 2019 (79 days ago) Price +0.00%

XRAY Dividend

Yield 0.73% / $0.40
Ex-Date Thu, Sep 26, 2019 (24 days ago)
Pay Date Fri, Oct 11, 2019
History 102 Payments (Quarterly)

XRAY Charts

$33.93
1 Year
$59.40
Oct 29, 2018
Jun 21, 2019


Medical Equipment And Devices
25 of 133
WST $140.85 0.76 (0.54%)
West Pharmaceutical Services
NYSE: WST $11 Billion Large-Cap. Show More

WST Profile

Market Cap 11 Billion
WST Description

West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (76% of 2018 sales) and contract-manufactured products (24%). The firm generates 56% of its revenue from international markets and 44% from the United States.


Visit Website

WST Earnings

EPS 0.90 P/E Ratio 51.33
Previous Thu, Jul 25, 2019
Latest Thu, Oct 24, 2019 (In 4 days)

WST Dividend

Yield 0.45% / $0.64
Ex-Date Tue, Oct 22, 2019 (In 2 days)
Pay Date Wed, Nov 6, 2019
History 140 Payments (Quarterly)

WST Charts

All Time High $152.10 on Fri, Sep 6, 2019.
$91.75
1 Year
$152.10
Dec 24, 2018
Sep 6, 2019


Medical Equipment And Devices
26 of 133
VAR $114.62 0.50 (0.44%)
Varian Medical Systems
NYSE: VAR $10 Billion Large-Cap. Show More

VAR Profile

Market Cap 10 Billion
VAR Description

Varian Medical Systems designs, manufactures, and sells radiation technology for use in two business segments: oncology systems and proton therapy. The Americas account for the largest portion of revenue (52%), followed by Europe, the Middle East, and Africa (29%) and Asia-Pacific (20%).


Visit Website

VAR Earnings

EPS 0.32 P/E Ratio 33.03
Previous Wed, Jul 24, 2019
Latest Wed, Oct 23, 2019 (In 3 days)

VAR Dividend

Yield --
Ex-Date --
Pay Date --
History 61 Payments (Quarterly)

VAR Charts

$101.42
1 Year
$142.50
Oct 23, 2018
Apr 1, 2019


Medical Equipment And Devices
27 of 133
PKI $83.10 0.08 (0.10%)
PerkinElmer Inc
NYSE: PKI $10 Billion Mid-Cap. Show More

PKI Profile

Market Cap 10 Billion
PKI Description

PerkinElmer provides instruments, consumables, and services to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes prenatal screening and infectious disease testing, and discovery and analytical solutions, composed of life science, industrial, environmental, and food applications. PerkinElmer offers products and services ranging from genetic screening to environmental analytical tools.


Visit Website

PKI Earnings

EPS 0.62 P/E Ratio 75.48
Previous Mon, Jul 29, 2019
Latest Wed, Oct 30, 2019 (In 10 days)

PKI Dividend

Yield 0.34% / $0.28
Ex-Date Thu, Oct 17, 2019 (3 days ago)
Pay Date Fri, Nov 8, 2019
History 137 Payments (Quarterly)

PKI Charts

All Time High $87.63 on Fri, Sep 20, 2019.
$78.35
1 Year
$87.63
Oct 8, 2019
Sep 20, 2019


Medical Equipment And Devices
28 of 133
PODD $153.74 2.74 (1.75%)
Insulet Corp
NASDAQ: PODD $9 Billion Mid-Cap. Show More

PODD Profile

Market Cap 9 Billion
PODD Description

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and a wireless personal diabetes manager that controls the dosage and has an integrated blood glucose meter. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 140,000-145,000 insulin-dependent diabetics are using it worldwide.


Visit Website

PODD Earnings

EPS 0.02 P/E Ratio 1648.60
Previous Mon, Aug 5, 2019
Latest Tue, Nov 5, 2019 (In 16 days)

PODD Dividend

Yield --
Ex-Date --
Pay Date --
History --

PODD Charts

All Time High $168.98 on Mon, Sep 30, 2019.
$70.80
1 Year
$168.98
Jan 3, 2019
Sep 30, 2019


Medical Equipment And Devices
29 of 133
ABMD $175.30 1.22 (0.69%)
Abiomed, Inc
NASDAQ: ABMD $8 Billion Mid-Cap. Show More

ABMD Profile

Market Cap 8 Billion
ABMD Description

Abiomed Inc provides temporary mechanical circulatory support devices that are primarily used by interventional cardiologists and heart surgeons. The firm's products are primarily used for patients in need of hemodynamic support before, during, or after angioplasty and heart surgery procedures. They work by improving blood flow to coronary arteries or temporarily performing the pumping function of the heart. Abiomed receives the majority of revenue from its Impella product portfolio, which includes percutaneous micro heart pumps with integration motors and sensors and percutaneous catheter-based axial flow pumps. Abiomed generates the majority of its revenue in the United States.


Visit Website

ABMD Earnings

EPS 1.97 P/E Ratio 54.25
Previous Thu, Aug 1, 2019
Latest Thu, Oct 31, 2019 (In 11 days)

ABMD Dividend

Yield --
Ex-Date --
Pay Date --
History --

ABMD Charts

52 Week Low $155.02 on Thu, Oct 10, 2019 .
$155.02
1 Year
$427.70
Oct 10, 2019
Nov 7, 2018


Medical Equipment And Devices
30 of 133
MASI $147.87 0.13 (0.09%)
Masimo Corp
NASDAQ: MASI $8 Billion Mid-Cap. Show More

MASI Profile

Market Cap 8 Billion
MASI Description

Masimo is an Irvine, California-based medical device business focusing on noninvasive patient monitoring. It began by developing superior signal processing algorithms to measure blood oxygenation levels through pulse oximetry and has expanded this expertise into a wide range of measurements and applications. The company generates revenue on a global basis, with the United States representing the largest market (68% of 2018 sales), followed by Europe, the Middle East and Africa (19%), Asia and Australia (10%), and North and South America excluding the U.S. (3%).


Visit Website

MASI Earnings

EPS 0.84 P/E Ratio 40.03
Previous Wed, Jul 31, 2019
Latest Wed, Oct 30, 2019 (In 10 days)

MASI Dividend

Yield --
Ex-Date --
Pay Date --
History --

MASI Charts

All Time High $160.25 on Wed, Jul 31, 2019.
$98.23
1 Year
$160.25
Dec 24, 2018
Jul 31, 2019


Medical Equipment And Devices
31 of 133
NVCR $74.93 3.01 (3.86%)
NovoCure Ltd
NASDAQ: NVCR $8 Billion Mid-Cap. Show More

NVCR Profile

Market Cap 8 Billion
NVCR Description

NovoCure Ltd serves in the healthcare sector of United States. Its business involves commercial stage oncology operations involving therapies to cure critical tumors. Its key offering is the TTFields therapy, which is a low-toxicity anti-mitotic treatment that uses low-intensity, intermediate frequency, alternating electric fields to exert physical forces on molecules inside cancer cells, thereby leading to cancer cell death. NovoCure derives its major revenues in the United States, through the sale of TTFields delivery system, which includes a portable electric field generator, transducer arrays, rechargeable batteries, and accessories.


Visit Website

NVCR Earnings

EPS -0.01 P/E Ratio 0.00
Previous Thu, Jul 25, 2019
Latest Thu, Oct 31, 2019 (In 11 days)

NVCR Dividend

Yield --
Ex-Date --
Pay Date --
History --

NVCR Charts

$26.02
1 Year
$98.70
Nov 20, 2018
Aug 21, 2019


Medical Equipment And Devices
32 of 133
HRC $102.03 0.19 (0.19%)
Hill-Rom Holdings Inc
NYSE: HRC $7 Billion Mid-Cap. Show More

HRC Profile

Market Cap 7 Billion
HRC Description

Hill-Rom Holdings is a global provider of hospital equipment and medical supplies, including hospital beds for high- and low-acuity settings. Hill-Rom reports financial data across three operating segments: patient support systems (50% of fiscal 2018 sales), front-line care (34%), and surgical solutions (16%). The firm has significant operations internationally, with roughly 30% of revenue derived from international sources and the remaining 70% from its U.S. business.


Visit Website

HRC Earnings

EPS 0.49 P/E Ratio 24.67
Previous Fri, Aug 2, 2019
Latest Fri, Nov 1, 2019 (In 12 days)

HRC Dividend

Yield 0.82% / $0.84
Ex-Date Thu, Sep 19, 2019 (31 days ago)
Pay Date Mon, Sep 30, 2019
History 140 Payments (Quarterly)

HRC Charts

All Time High $109.18 on Thu, Aug 1, 2019.
$81.82
1 Year
$109.18
Oct 31, 2018
Aug 1, 2019


Medical Equipment And Devices
33 of 133
HAE $127.25 0.11 (0.09%)
Haemonetics Corp
NYSE: HAE $6 Billion Mid-Cap. Show More

HAE Profile

Market Cap 6 Billion
HAE Description

Haemonetics Corp sells products used to process, handle, and analyze blood. The firm sells products in four categories: Plasma, Hemostasis Management, Blood Center and Cell Processing. The Plasma business includes plasma collection devices and disposables. Hemostasis Management includes devices and methodologies for measuring coagulation characteristics of blood, Blood Center includes blood collection and processing devices and disposables for red cells and Cell Processing include surgical blood salvage systems, specialized blood cell processing systems, disposables and blood transfusion management software.


Visit Website

HAE Earnings

EPS -0.17 P/E Ratio 262.00
Previous Tue, Aug 6, 2019
Latest Fri, Nov 1, 2019 (In 12 days)

HAE Dividend

Yield --
Ex-Date --
Pay Date --
History --

HAE Charts

$80.24
1 Year
$140.36
Apr 18, 2019
Aug 19, 2019


Medical Equipment And Devices
34 of 133
IART $62.49 0.53 (0.86%)
Integra Lifesciences Holdings Corp
NASDAQ: IART $5 Billion Mid-Cap. Show More

IART Profile

Market Cap 5 Billion
IART Description

Integra Lifesciences is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical (65% of 2018 sales) and orthopedics and tissue technologies (35%). Integra earns approximately 30% of sales internationally, with the remainder derived from the United States.


Visit Website

IART Earnings

EPS 0.35 P/E Ratio 71.03
Previous Wed, Jul 24, 2019
Latest Thu, Oct 24, 2019 (In 4 days)

IART Dividend

Yield --
Ex-Date --
Pay Date --
History --

IART Charts

All Time High $67.50 on Mon, Jun 18, 2018.
$42.14
1 Year
$65.09
Jan 3, 2019
Jul 31, 2019


Medical Equipment And Devices
35 of 133
GMED $51.40 0.39 (0.76%)
Globus Medical Inc
NYSE: GMED $5 Billion Mid-Cap. Show More

GMED Profile

Market Cap 5 Billion
GMED Description

Globus Medical is a medical device company that develops products for patients with musculoskeletal disorders. The firm's products are organized into two categories: innovative fusion and disruptive technologies. The innovative fusion products include fusion products that treat a variety of spinal disorders and can be used in several surgical applications. The disruptive technology products are used for applications such as minimally invasive surgery and new treatment alternatives, including motion preservation and regenerative biologic technologies. Globus Medical generates the vast majority of its revenue in the United States.


Visit Website

GMED Earnings

EPS 0.39 P/E Ratio 35.36
Previous Thu, Aug 1, 2019
Latest Wed, Nov 6, 2019 (In 17 days)

GMED Dividend

Yield --
Ex-Date --
Pay Date --
History --

GMED Charts

$38.01
1 Year
$57.83
Jan 3, 2019
Nov 8, 2018


Medical Equipment And Devices
36 of 133
PEN $147.21 0.31 (0.21%)
Penumbra Inc
NYSE: PEN $5 Billion Mid-Cap. Show More

PEN Profile

Market Cap 5 Billion
PEN Description

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for the neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.


Visit Website

PEN Earnings

EPS 0.48 P/E Ratio 792.72
Previous Tue, May 7, 2019
Latest Tue, Aug 6, 2019 (75 days ago) Price +0.00%

PEN Dividend

Yield --
Ex-Date --
Pay Date --
History --

PEN Charts

$110.84
1 Year
$185.70
Dec 24, 2018
Jul 25, 2019


Medical Equipment And Devices
37 of 133
LIVN $74.66 0.67 (0.91%)
LivaNova PLC
NASDAQ: LIVN $4 Billion Mid-Cap. Show More

LIVN Profile

Market Cap 4 Billion
LIVN Description

LivaNova is a London-based medical device company that develops and manufactures products for use in epilepsy treatment and interventional cardiology. With the divestiture of the company's cardiac rhythm management division now complete, the firm reports in two primary segments: cardiac surgery (roughly 60% of 2018 sales) and neuromodulation (40%). The company's revenue mix shifted further toward the U.S. after the divestiture, with roughly 50% of total sales derived from the U.S., 20% from Europe, and 30% from the rest of the world.


Visit Website

LIVN Earnings

EPS -0.60 P/E Ratio 0.00
Previous Wed, Jul 31, 2019
Latest Wed, Oct 30, 2019 (In 10 days)

LIVN Dividend

Yield --
Ex-Date --
Pay Date --
History --

LIVN Charts

$64.80
1 Year
$126.99
May 1, 2019
Nov 16, 2018


Medical Equipment And Devices
38 of 133
TNDM $63.58 0.55 (0.87%)
Tandem Diabetes Care Inc
NASDAQ: TNDM $4 Billion Mid-Cap. Show More

TNDM Profile

Market Cap 4 Billion
TNDM Description

Tandem Diabetes Care Inc is a medical device company that develops products for people with insulin-dependent diabetes. The firm has three key insulin pump products. The t:slim Insulin Delivery System can easily fit into a user's pocket. The t:flex Insulin Delivery System is used by customers with greater insulin needs. The t:slim G4 Insulin Delivery system is a continuous glucose monitoring enabled pump with a touch screen. Tandem Diabetes also sells pump-related supplies and accessories. Pump sales contribute the majority of revenue. The firm generates virtually all of its revenue in the United States.


Visit Website

TNDM Earnings

EPS -0.03 P/E Ratio 0.00
Previous Thu, Aug 1, 2019
Latest Mon, Nov 4, 2019 (In 15 days)

TNDM Dividend

Yield --
Ex-Date --
Pay Date --
History --

TNDM Charts

$26.40
1 Year
$74.81
Nov 20, 2018
Mar 21, 2019


Medical Equipment And Devices
39 of 133
CMD $71.06 1.11 (1.54%)
Cantel Medical Corp. Common Stock
NYSE: CMD $4 Billion Mid-Cap. Show More

CMD Profile

Market Cap 4 Billion
CMD Description

Cantel Medical is a New Jersey-based manufacturer of hospital supplies for infection prevention, which include products used in endoscope disinfection, water purification systems for use in dialysis treatment, and disposable supplies in the dental office. The firm reports in four segments: Endoscopy (54% of fiscal 2018 sales), Water Purification and Filtration (24%), Healthcare Disposables (18%), and Dialysis (4%). Geographic exposure is primarily in the U.S., which accounts for 75% of revenue, with international markets making up the remaining 25%.


Visit Website

CMD Earnings

EPS 0.21 P/E Ratio 75.90
Previous Tue, Jun 4, 2019
Latest Mon, Sep 23, 2019 (27 days ago) Price +0.00%

CMD Dividend

Yield 0.28% / $0.20
Ex-Date Tue, Jul 16, 2019 (96 days ago)
Pay Date Wed, Jul 31, 2019
History 20 Payments (Biannual)

CMD Charts

$63.47
1 Year
$93.87
Apr 18, 2019
Jul 31, 2019


Medical Equipment And Devices
40 of 133
NUVA $66.53 1.24 (1.90%)
NuVasive Inc
NASDAQ: NUVA $3 Billion Mid-Cap. Show More

NUVA Profile

Market Cap 3 Billion
NUVA Description

NuVasive Inc is a medical-device company focused on minimally invasive surgical products and integrated solutions for spine surgery. The firm's spine surgery products contribute the majority of revenue. Its key offering is the maximum access surgery minimally disruptive surgical platform, which minimizes soft-tissue disruption and contact with critical nerves and maximizes visualization during spine fusion surgery. NuVasive also develops biologics used to aid in the spinal fusion or bone-healing processes, such as a collagen-based synthetic bone substitute and synthetic bone-graft material. NuVasive generates the majority of its revenue in the United States.


Visit Website

NUVA Earnings

EPS 0.29 P/E Ratio 131.71
Previous Tue, Jul 30, 2019
Latest Wed, Oct 30, 2019 (In 10 days)

NUVA Dividend

Yield --
Ex-Date --
Pay Date --
History --

NUVA Charts

$43.51
1 Year
$69.10
Jan 8, 2019
Aug 1, 2019


Medical Equipment And Devices
41 of 133
ICUI $155.75 0.88 (0.56%)
ICU Medical Inc
NASDAQ: ICUI $3 Billion Mid-Cap. Show More

ICUI Profile

Market Cap 3 Billion
ICUI Description

ICU Medical is a California-based medical equipment company that offers infusion systems, administration sets and accessories, and IV fluids to acute care customers. Historically, the company had focused almost exclusively on the sale of administration sets and consumables, which changed following its 2017 acquisition of the Hospira Infusion Systems assets from Pfizer. The firm now earns revenue through four primary segments; infusion consumables (36% 2018 pro forma sales), IV solutions (33%), infusion systems (27%), and critical care (4%). The combined entity remains primarily U.S. focused, with roughly 75% of sales coming from domestic markets and the remaining 25% from international geographies.


Visit Website

ICUI Earnings

EPS 1.11 P/E Ratio 166.76
Previous Thu, May 9, 2019
Latest Wed, Aug 7, 2019 (74 days ago) Price +0.00%

ICUI Dividend

Yield --
Ex-Date --
Pay Date --
History --

ICUI Charts

52 Week Low $148.89 on Wed, Oct 16, 2019 .
$148.89
1 Year
$284.69
Oct 16, 2019
Oct 22, 2018


Medical Equipment And Devices
42 of 133
CNMD $97.58 0.40 (0.41%)
Conmed Corp
NASDAQ: CNMD $3 Billion Mid-Cap. Show More

CNMD Profile

Market Cap 3 Billion
CNMD Description

Conmed Corporation is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery (52% of 2018 sales) and general surgery (48%). From a geographic perspective the firm is U.S. centric, with domestic sales accounting for 52% of revenue, EMEA accounting for 19%, APAC at 17%, and the non-U.S. Americas region driving the remaining 12%.


Visit Website

CNMD Earnings

EPS 0.20 P/E Ratio 56.33
Previous Wed, Jul 31, 2019
Latest Wed, Oct 30, 2019 (In 10 days)

CNMD Dividend

Yield 0.82% / $0.80
Ex-Date Thu, Sep 12, 2019 (38 days ago)
Pay Date Mon, Oct 7, 2019
History 31 Payments (Quarterly)

CNMD Charts

All Time High $103.90 on Tue, Sep 17, 2019.
$56.91
1 Year
$103.90
Dec 26, 2018
Sep 17, 2019


Medical Equipment And Devices
43 of 133
NVRO $85.00 0.41 (0.48%)
Nevro Corp
NYSE: NVRO $3 Billion Mid-Cap. Show More

NVRO Profile

Market Cap 3 Billion
NVRO Description

Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany.


Visit Website

NVRO Earnings

EPS -0.91 P/E Ratio 0.00
Previous Thu, Aug 8, 2019
Latest Wed, Nov 6, 2019 (In 17 days)

NVRO Dividend

Yield --
Ex-Date --
Pay Date --
History --

NVRO Charts

$34.75
1 Year
$91.60
Dec 20, 2018
Sep 12, 2019


Medical Equipment And Devices
44 of 133
GKOS $64.76 0.21 (0.32%)
Glaukos Corp
NYSE: GKOS $3 Billion Mid-Cap. Show More

GKOS Profile

Market Cap 3 Billion
GKOS Description

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.


Visit Website

GKOS Earnings

EPS -0.17 P/E Ratio 0.00
Previous Wed, May 8, 2019
Latest Wed, Aug 7, 2019 (74 days ago) Price +0.00%

GKOS Dividend

Yield --
Ex-Date --
Pay Date --
History --

GKOS Charts

$50.60
1 Year
$84.65
Jan 3, 2019
Aug 1, 2019


Medical Equipment And Devices
45 of 133
WMGI $20.81 0.11 (0.53%)
Wright Medical Group NV
NASDAQ: WMGI $3 Billion Mid-Cap. Show More

WMGI Profile

Market Cap 3 Billion
WMGI Description

Wright Medical Group develops medical devices and products in five categories: lower extremities, upper extremities, biologics, large joints, and sport medicine, and other. Products for lower extremities include joint implants and bone fixation devices for the foot and ankle, whereas products for upper extremities include implants and devices for the shoulder, elbow, wrist, and hand. The biologics business sells products used to treat damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The large joints business sells hip and knee replacement implants. The firm's sports medicine products are used to mechanically repair tissue injuries. Wright Medical Group generates the majority of its revenue in the United States.


Visit Website

WMGI Earnings

EPS -0.14 P/E Ratio 0.00
Previous Wed, Aug 7, 2019
Latest Wed, Nov 6, 2019 (In 17 days)

WMGI Dividend

Yield --
Ex-Date --
Pay Date --
History --

WMGI Charts

52 Week Low $19.04 on Tue, Sep 24, 2019 .
$19.04
1 Year
$32.86
Sep 24, 2019
Mar 4, 2019


Medical Equipment And Devices
46 of 133
ITGR $74.99 0.51 (0.68%)
Integer Holdings Corp
NYSE: ITGR $2 Billion Mid-Cap. Show More

ITGR Profile

Market Cap 2 Billion
ITGR Description

Integer Holdings Corp manufactures and develops medical devices and components for original-equipment manufacturers. The firm's main segments are Greatbatch Medical and Lake Region Medical. The Greatbatch Medical segment contributes the largest proportion of revenue. It designs products for which the firm owns or licenses the intellectual property or has manufacturing expertise. This business also uses the firm's technologies to offer assembly and design engineering services for medical devices. The Lake Region Medical segment designs medical components and devices for the cardiovascular and advanced surgical markets. Integer Holdings generates roughly half of its revenue in the United States.


Visit Website

ITGR Earnings

EPS 1.01 P/E Ratio 42.43
Previous Thu, May 2, 2019
Latest Thu, Aug 1, 2019 (80 days ago) Price +0.00%

ITGR Dividend

Yield --
Ex-Date --
Pay Date --
History --

ITGR Charts

$67.72
1 Year
$92.62
May 1, 2019
Mar 1, 2019


Medical Equipment And Devices
47 of 133
AVNS $40.56 1.12 (2.84%)
Avanos Medical, Inc. Common Stock
NYSE: AVNS $2 Billion Mid-Cap. Show More

AVNS Earnings

EPS -0.17 P/E Ratio 0.00
Previous Tue, May 7, 2019
Latest Tue, Aug 6, 2019 (75 days ago) Price +0.00%

AVNS Dividend

Yield --
Ex-Date --
Pay Date --
History --

AVNS Charts

$31.78
1 Year
$61.33
Aug 28, 2019
Oct 19, 2018


Medical Equipment And Devices
48 of 133
IRTC $69.12 3.10 (4.29%)
iRhythm Technologies Inc
NASDAQ: IRTC $2 Billion Mid-Cap. Show More